18 filings
8-K
VOR
Vor Biopharma Inc
10 Jun 24
Departure of Directors or Certain Officers
4:05pm
8-K
VOR
Vor Biopharma Inc
28 May 24
Departure of Directors or Certain Officers
4:54pm
8-K
VOR
Vor Biopharma Inc
2 May 24
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
4:07pm
8-K
VOR
Vor Biopharma Inc
5 Jan 24
Other Events
5:03pm
8-K
VOR
Vor Biopharma Inc
2 Nov 23
Multiple Clinical and Preclinical Presentations at ASH 2023
9:10am
8-K
7278inc b5uj
9 Jun 23
Regulation FD Disclosure
7:41am
8-K
1p0flj55fdq3 6a
26 May 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
sd5b257t7g hi1x
14 Apr 23
Departure of Directors or Certain Officers
4:01pm
8-K
a34wsr30394gy7l3p
16 Feb 23
Regulation FD Disclosure
12:13pm
8-K
2fzsq4
23 Dec 22
Entry into a Material Definitive Agreement
4:07pm
8-K
lwbxl5vjj1k1p
14 Dec 22
Termination of a Material Definitive Agreement
4:32pm
8-K
3fb mbsyctegr
7 Dec 22
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent
4:59pm
8-K
h6cfwcr7oj12ghrta
7 Dec 22
Regulation FD Disclosure
7:36am
8-K
4fq0grj1fa
29 Nov 22
Regulation FD Disclosure
10:25am
8-K
k5a2mp6 b1fcux
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
eo2drinxo4u
14 Apr 22
Departure of Directors or Certain Officers
4:01pm
8-K
pjtkz d10rb
17 Jun 21
Entry into a Material Definitive Agreement
8:13am
8-K
qsqlqwp
9 Feb 21
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to
4:21pm
- Prev
- 1
- Next